These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30197514)

  • 1. Magnetic nanoparticle hyperthermia potentiates paclitaxel activity in sensitive and resistant breast cancer cells.
    Rivera-Rodriguez A; Chiu-Lam A; Morozov VM; Ishov AM; Rinaldi C
    Int J Nanomedicine; 2018; 13():4771-4779. PubMed ID: 30197514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy.
    Giovinazzi S; Bellapu D; Morozov VM; Ishov AM
    Cell Cycle; 2013 Aug; 12(16):2598-607. PubMed ID: 23907120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term hyperthermia promotes the sensitivity of MCF-7 human breast cancer cells to paclitaxel.
    Lin Y; Liu Z; Li Y; Liao X; Liao S; Cen S; Yang L; Wei J; Hu X
    Biol Pharm Bull; 2013; 36(3):376-83. PubMed ID: 23229357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
    Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the combination of Chemo/Magnetocaloric therapy on MDA-MB-231 cells.
    Cai D; Liu L; Han C; Ma X; Qian J; Zhou J; Zhu W
    Sci Rep; 2019 Oct; 9(1):14475. PubMed ID: 31597929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crocin enhances the sensitivity to paclitaxel in human breast cancer cells by reducing BIRC5 expression.
    Jia Y; Yang H; Yu J; Li Z; Jia G; Ding B
    Chem Biol Drug Des; 2024 Feb; 103(2):e14467. PubMed ID: 38661582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models.
    Lugert S; Unterweger H; Mühlberger M; Janko C; Draack S; Ludwig F; Eberbeck D; Alexiou C; Friedrich RP
    Int J Nanomedicine; 2019; 14():161-180. PubMed ID: 30613144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
    Wang Y; Yu L; Han L; Sha X; Fang X
    Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS; Cho CW
    J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
    Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
    Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
    Meng L; Xia X; Yang Y; Ye J; Dong W; Ma P; Jin Y; Liu Y
    Int J Pharm; 2016 Nov; 513(1-2):8-16. PubMed ID: 27596118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication and evaluation of aptamer-conjugated paclitaxel-loaded magnetic nanoparticles for targeted therapy on breast cancer cells.
    Khodadadi E; Mahjoub S; Arabi MS; Najafzadehvarzi H; Nasirian V
    Mol Biol Rep; 2021 Mar; 48(3):2105-2116. PubMed ID: 33635469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to Intervention: Paclitaxel in Breast Cancer.
    Dan VM; Raveendran RS; Baby S
    Mini Rev Med Chem; 2021; 21(10):1237-1268. PubMed ID: 33319669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells.
    Diab T; Alkafaas SS; Shalaby TI; Hessien M
    Anticancer Agents Med Chem; 2020; 20(13):1582-1591. PubMed ID: 32364081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Profiling of Paclitaxel Treated Cells Identifies a Novel Mechanism of Drug Resistance Mediated by PDCD4.
    Xu H; Dephoure N; Sun H; Zhang H; Fan F; Liu J; Ning X; Dai S; Liu B; Gao M; Fu S; Gygi SP; Zhou C
    J Proteome Res; 2015 Jun; 14(6):2480-91. PubMed ID: 25928036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel.
    Othman T; Goto S; Lee JB; Taimura A; Matsumoto T; Kosaka M
    Pharmacology; 2001 May; 62(4):208-12. PubMed ID: 11359996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P; Robey R; Fojo T; Blagosklonny MV
    Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.